Sponsor pipeline

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University clinical trial pipeline

Get alerts when Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.

  1. Notable

    Primary completion pushed from Dec 30, 2024 to Dec 30, 2026

    Also in this update: Enrollment closed, study ongoing; Study completion pushed from Oct 30, 2026 to Oct 30, 2027

    Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityPhase 2 NCT06081673 Registry history

    Updated

Show 1 trial with minor changes only
  1. Minor

    Primary and study completion pushed from Aug 31, 2028 to Sep 30, 2028

    Also in this update: Trial sites expanded: 1 → 12 locations

    Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityNot applicable NCT07774728 Registry history

    Updated

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Early Phase 1
1
Phase 1/2
1
Phase 2
17
Phase 2/3
2
Phase 3
3
Phase 4
1
Not charted: 33 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials top 25 of 58

NCT IDTitleConditionStatusUpdated
Phase 4
NCT06927375 A Study on the Combined Use of Tocilizumab and Flupentixol-Melitracen in the Treatment of… Thyroid-Associated Ophthalmopathy Recruiting 2025-04-16
Phase 3
NCT07445048 Postoperative Radiotherapy Combined With Nimotuzumab Followed by Benmelstobart in… Head & Neck Squamous Cell Carcinoma Recruiting 2026-04-17
NCT07320690 De-Escalation Surgery After Immunotherapy in Locally Advanced Head and Neck Squamous Cell… Squamous Cell Carcinoma of the Head and Neck Not Yet Recruiting 2026-01-06
NCT06647563 Neoadjuvant Toripalimab + Chemotherapy ± Cetuximab in Locally Advanced Head and Neck… Squamous Cell Carcinoma of Head and Neck Not Yet Recruiting 2024-10-18
Phase 2/3
NCT07535567 Postoperative Radiotherapy With Nimotuzumab ± Benmelstobart in Intermediate-Risk Head and… Head and Neck Squamous Cell Carcinoma Not Yet Recruiting 2026-04-30
NCT06819605 Neoadjuvant Therapy With Conservative Surgery vs. Up-front Conservative Surgery for BRAF… Ameloblastoma Not Yet Recruiting 2025-02-11
Phase 2
NCT07815522 Abiraterone With Dalpiciclib in Salivary Gland Carcinoma Salivary Gland Carcinoma Recruiting 2026-09-11
NCT07029178 Taurine's Therapeutic Effect on Acute Radiation-induced Oral Mucositis and Dermatitis Radiation Induced Oral Mucositis Recruiting 2026-07-23
NCT07662746 Efficacy and Safety of Paclitaxel Polymeric Micelles in Patients With… Head and Neck Cancer Recruiting 2026-06-23
NCT07088211 Sacituzumab Tirumotecan and Toripalimab in the First-line Treatment of HNSCC Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Recruiting 2026-06-18
NCT07090317 Iparomlimab and Tuvonralimab in HNSCC Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Recruiting 2026-06-18
NCT07632339 Becotatug Vedotin Combined With Pucotenlimab for Locally Recurrent Resectable Head and… Head and Neck Cancer Recruiting 2026-06-08
NCT06935188 Dalpicilib Plus Cetuximab Compared With Cetuximab Alone in HPV-negative… Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Recruiting 2025-07-18
NCT06876844 Surufatinib Combined with Envolizumab As Second-line Treatment for Recurrent/Metastatic… Head and Neck Cancer Recruiting 2025-03-14
NCT06470217 Tirilizumab with Albumin-bound Paclitaxel and Cisplatin for Locally Advanced Resectable… Locally Advanced Head and Neck Squamous Cell Carcinoma Recruiting 2025-02-11
NCT06653517 Clinical Study of Neoadjuvant Targeted Therapy for Ameloblastoma Ameloblastoma Recruiting 2024-10-22
NCT06503276 The Treatment of Ocular Adnexal Extranodal Marginal Zone B-cell Lymphoma by Orelabrutinib… Extranodal Marginal Zone B-cell Lymphoma Recruiting 2024-07-22
NCT06081673 Penpulimab Combined With Chemotherapy for Neoadjuvant and Adjuvant Therapy in Patients… Head and Neck Squamous Cell Carcinoma Active, Not Recruiting 2026-09-30
NCT07728201 Response-adapted Luvometinib With or Without Cytarabine in Langerhans Cell Histiocytosis Langerhans Cell Histiocytosis Not Yet Recruiting 2026-07-27
NCT07579598 ADC and SBRT for Recurrent/Metastatic Salivary Gland Carcinoma Adenoid Cystic Carcinoma of the Head and Neck Not Yet Recruiting 2026-05-12
NCT07353073 A Prospective, Single-Arm, Phase II Clinical Study of Neoadjuvant Therapy With… Head and Neck Mucosal Melanomas Not Yet Recruiting 2026-01-20
NCT05586100 Neoadjuvant and Adjuvant Toripalimab and Cetuximab in Patients With Recurrent, Resectable… Patients With Locally Recurrent Resectable Head and Neck Squamous Cell Carcinoma Active, Not Recruiting 2025-07-31
NCT06728631 Candonilimab and ATRA Acid for Prevention of Oral Cancer Recurrence in Patients With OPL Oral Cavity Cancer Active, Not Recruiting 2025-02-24
Phase 1/2
NCT07662681 Camrelizumab With Famitinib for Patients With Rare Head and Neck Malignancies Head and Neck Cancer Recruiting 2026-06-23
Early Phase 1
NCT05883293 Clinical Study of Allogeneic Fat Decellularized Active Protein in the Treatment of… Pulmonary Fibrosis Active, Not Recruiting 2025-09-19
See all 58 active Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University trials with filters →

Disease areas by active trials

Head & Neck Cancer (22) · Chronic Kidney Disease (2) · Melanoma (2) · Alzheimer's Disease (1) · COPD (1) · Dementia (1) · Non-Hodgkin Lymphoma (1)

Get alerts when Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free